Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Dixon, Brian M ^a   Barker, Tyler ^b   McKinnon, Toni ^a   Cuomo, John ^a   Frei, Balz ^c   Borregaard, Niels ^d   Gombart, Adrian F ^c  

^a USANA Health Sciences Inc   (United States)

^b Orthopedic Specialty Hospital   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

25 hydroxyvitamin D; CAMP; Cathelicidin; hCAP18; Immunity; Infection; LL 37; Plasma; Serum; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE; DRUG DERIVATIVE; VITAMIN D;

ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; MALE; MIDDLE AGED; REFERENCE VALUE;

ADULT; CATHELICIDINS; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; VITAMIN D;

EID: 84867682015     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-575     Document Type: Article

References (45)

1. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL, Nature 2001 414 6862 454 457 10.1038/35106587 11719807
2. Cathelicidin-deficient (Cnlp -/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Huang LC, Reins RY, Gallo RL, McDermott AM, Invest Ophthalmol Vis Sci 2007 48 10 4498 4508 10.1167/iovs.07-0274 17898271
3. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, Ehren I, Hokfelt T, Gudmundsson GH, Gallo RL, Agerberth B, et al. Nat Med 2006 12 6 636 641 10.1038/nm1407 16751768
4. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF, J Immunol 2005 174 8 4901 4907 15814717
5. Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide. Yu FS, Cornicelli MD, Kovach MA, Newstead MW, Zeng X, Kumar A, Gao N, Yoon SG, Gallo RL, Standiford TJ, J Immunol 2010 185 2 1142 1149 10.4049/jimmunol.1000509 20566829
6. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY, N Engl J Med 2002 347 15 1151 1160 10.1056/NEJMoa021481 12374875
7. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Putsep K, Carlsson G, Boman HG, Andersson M, Lancet 2002 360 9340 1144 1149 10.1016/S0140-6736(02)11201-3 12387964
8. Neutrophil specific granule deficiency and mutations in the gene encoding transcription factor C/EBP(epsilon). Gombart AF, Koeffler HP, Curr Opin Hematol 2002 9 1 36 42 10.1097/00062752-200201000-00007 11753076
9. Expression of LL-37/hCAP-18 gene in human leukemia cells. Yang YH, Zheng GG, Li G, Zhang B, Song YH, Wu KF, Leuk Res 2003 27 10 947 950 10.1016/S0145-2126(03)00020-1 12860015
10. Marked reduction of LL-37/hCAP-18, an antimicrobial peptide, in patients with acute myeloid leukemia. An LL, Ma XT, Yang YH, Lin YM, Song YH, Wu KF, Int J Hematol 2005 81 1 45 47 10.1532/IJH97.A10407 15717688
11. Host defense peptides in burns. Steinstraesser L, Oezdogan Y, Wang SC, Steinau HU, Burns 2004 30 7 619 627 10.1016/j.burns.2004.05.013 15475133
12. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Bals R, Weiner DJ, Moscioni AD, Meegalla RL, Wilson JM, Infect Immun 1999 67 11 6084 6089 10531270
13. Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections. Jacobsen F, Mittler D, Hirsch T, Gerhards A, Lehnhardt M, Voss B, Steinau HU, Steinstraesser L, Gene Ther 2005 12 20 1494 1502 10.1038/sj.gt.3302568 15973442
14. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Raqib R, Sarker P, Bergman P, Ara G, Lindh M, Sack DA, Nasirul Islam KM, Gudmundsson GH, Andersson J, Agerberth B, Proc Natl Acad Sci USA 2006 103 24 9178 9183 10.1073/pnas.0602888103 16740661
15. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Gombart AF, Future Microbiol 2009 4 9 1151 1165 10.2217/fmb.09.87 19895218
16. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH, Proc Natl Acad Sci USA 1995 92 1 195 199 10.1073/pnas.92.1.195 7529412
17. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC, Infect Immun 1995 63 4 1291 1297 7890387
18. hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. Cowland JB, Johnsen AH, Borregaard N, FEBS Lett 1995 368 1 173 176 10.1016/0014-5793(95)00634-L 7615076
19. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, Borregaard N, Blood 2001 97 12 3951 3959 10.1182/blood.V97.12.3951 11389039
20. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. Gombart AF, Borregaard N, Koeffler HP, FASEB J 2005 19 9 1067 1077 10.1096/fj.04-3284com 15985530
21. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, et al. J Immunol 2004 173 5 2909 2912 15322146
22. Vitamin D induces the antimicrobial protein hCAP18 in human skin. Weber G, Heilborn JD, Chamorro Jimenez CI, Hammarsjo A, Torma H, Stahle M, J Invest Dermatol 2005 124 5 1080 1082 10.1111/j.0022-202X.2005.23687.x 15854055
23. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, Kiessling R, Jornvall H, Wigzell H, Gudmundsson GH, Blood 2000 96 9 3086 3093 11049988
24. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Sorensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N, Blood 1997 90 7 2796 2803 9326247
25. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Frohm Nilsson M, Sandstedt B, Sorensen O, Weber G, Borregaard N, Stahle-Backdahl M, Infect Immun 1999 67 5 2561 2566 10225921
26. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Bals R, Wang X, Zasloff M, Wilson JM, Proc Natl Acad Sci USA 1998 95 16 9541 9546 10.1073/pnas.95.16.9541 9689116
27. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. Murakami M, Ohtake T, Dorschner RA, Gallo RL, J Dent Res 2002 81 12 845 850 10.1177/154405910208101210 12454100
28. The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Malm J, Sorensen O, Persson T, Frohm-Nilsson M, Johansson B, Bjartell A, Lilja H, Stahle-Backdahl M, Borregaard N, Egesten A, Infect Immun 2000 68 7 4297 4302 10.1128/IAI.68.7.4297-4302.2000 10858248
29. Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes. Andersson E, Sorensen OE, Frohm B, Borregaard N, Egesten A, Malm J, Hum Reprod 2002 17 10 2529 2534 10.1093/humrep/17.10.2529 12351523
30. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. Sorensen O, Cowland JB, Askaa J, Borregaard N, J Immunol Methods 1997 206 1-2 53 59 9328568
31. Regulation of the CAMP gene by 1,25(OH)2D3 in various tissues. Gombart AF, O'Kelly J, Saito T, Koeffler HP, J Steroid Biochem Mol Biol 2007 103 3-5 552 557 17368184
32. Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Schauber J, Dorschner RA, Yamasaki K, Brouha B, Gallo RL, Immunology 2006 118 4 509 519 16895558
33. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, et al. Science 2006 311 5768 1770 1773 10.1126/science.1123933 16497887
34. Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA Jr, Koeffler HP, Thadhani R, Clin Infect Dis 2009 48 4 418 424 10.1086/596314 19133797
35. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, Borregaard N, Modlin RL, Hewison M, J Immunol 2009 182 7 4289 4295 10.4049/jimmunol.0803736 19299728
36. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, Tangpricha V, J Transl Med 2009 7 28 10.1186/1479-5876-7-28 19389235
37. Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults. Bhan I, Camargo CA Jr, Wenger J, Ricciardi C, Ye J, Borregaard N, Thadhani R, J Allergy Clin Immunol 2011 127 5 1302 1304 e1. Epub 2011 Feb 9. No abstract available. PMID: 21310475 10.1016/j.jaci.2010.12.1097 21310475
38. A rapid method of total lipid extraction and purification. WJ BEaD, Can J Biochem Physiol 1959 37 911 917 10.1139/o59-099 13671378
39. Assay of vitamins D2 and D3, and 25-hydroxyvitamins D2 and D3 in human plasma by high-performance liquid chromatography. Jones G, Clin Chem 1978 24 2 287 298 203413
40. Age and low levels of circulating vitamin D are associated with impaired innate immune function. Alvarez-Rodriguez L, Lopez-Hoyos M, Garcia-Unzueta M, Amado JA, Cacho PM, Martinez-Taboada VM, J Leukoc Biol 2012 91 5 829 838 10.1189/jlb.1011523 22345707
41. Maternal plasma level of antimicrobial peptide LL37 is a major determinant factor of neonatal plasma LL37 level. Mandic Havelka A, Yektaei-Karin E, Hultenby K, Sorensen OE, Lundahl J, Berggren V, Marchini G, Acta Paediatr 2010 99 6 836 841 10.1111/j.1651-2227.2010.01726.x 20178514
42. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Yamshchikov AV, Kurbatova EV, Kumari M, Blumberg HM, Ziegler TR, Ray SM, Tangpricha V, Am J Clin Nutr 2010 92 3 603 611 10.3945/ajcn.2010.29411 20610636
43. Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease. Jiang H, Schiffer E, Song Z, Wang J, Zurbig P, Thedieck K, Moes S, Bantel H, Saal N, Jantos J, et al. Proc Natl Acad Sci USA 2008 105 32 11299 11304 10.1073/pnas.0801457105 18695223
44. ELISA for aging biomarkers induced by telomere dysfunction in human plasma. Jiang H, Chen W, Qu L, Chen Y, He Q, Wang H, Wu J, Shou Z, Ju Z, Chen J, J Biomed Biotechnol 2010 2010 121947 21127712
45. Administration of oral vitamin D induces cathelicidin production in atopic individuals. Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, Udall D, Kanada K, Yamasaki K, Alexandrescu D, Gallo RL, J Allergy Clin Immunol 2008 122 4 829 831 10.1016/j.jaci.2008.08.020 19014773